Match!
Martin O'Donnell
National University of Ireland, Galway
249Publications
50H-index
36.3kCitations
Publications 249
Newest
Published on Dec 1, 2019in BMC Medical Research Methodology2.51
John Ferguson8
Estimated H-index: 8
(National University of Ireland, Galway),
Neil O’Leary4
Estimated H-index: 4
(National University of Ireland, Galway)
+ 2 AuthorsMartin O'Donnell50
Estimated H-index: 50
(National University of Ireland, Galway)
Background Population attributable fractions (PAF) measure the proportion of disease prevalence that would be avoided in a hypothetical population, similar to the population of interest, but where a particular risk factor is eliminated. They are extensively used in epidemiology to quantify and compare disease burden due to various risk factors, and directly influence public policy regarding possible health interventions. In contrast to individual specific metrics such as relative risks and odds ...
Published on Jan 8, 2019in Systematic Reviews
Francesca Wuytack6
Estimated H-index: 6
(Trinity College, Dublin),
Maria Regan (National University of Ireland, Galway)+ 5 AuthorsDeclan Devane29
Estimated H-index: 29
(National University of Ireland, Galway)
Systematic reviews of randomised trials guide policy and healthcare decisions. Yet, we observed that some reviews judge randomised trials as high or unclear risk of bias (ROB) for sequence generation, potentially introducing bias. However, to date, the extent of this issue has not been well examined. We evaluated the consistency in the ROB assessment for sequence generation of randomised trials in Cochrane and non-Cochrane reviews, and explored the reviewers’ judgement of the quality of evidence...
Published on Sep 16, 2019in Age and Ageing4.51
Catriona Reddin (University Hospital Galway), Robert Murphy (University Hospital Galway)+ 11 AuthorsMartin O'Donnell50
Estimated H-index: 50
(University Hospital Galway)
Published on Sep 16, 2019in Age and Ageing4.51
Robert Murphy (National University of Ireland, Galway), Catriona Reddin2
Estimated H-index: 2
(National University of Ireland, Galway)
+ 11 AuthorsC Egan (National University of Ireland, Galway)
Published on Sep 12, 2019in Circulation23.05
John W. Eikelboom89
Estimated H-index: 89
(Population Health Research Institute),
Stuart J. Connolly53
Estimated H-index: 53
(Population Health Research Institute)
+ 19 AuthorsDeepak L. Bhatt119
Estimated H-index: 119
(Brigham and Women's Hospital)
Background: Patients treated with antithrombotic drugs are at risk of bleeding. Bleeding may be the first manifestation of underlying cancer. Methods: We examined new cancers diagnosed in relation ...
Published on Sep 1, 2019in The Lancet59.10
Salim Yusuf Mb Bs DPhil Frcpc209
Estimated H-index: 209
(Population Health Research Institute),
Philip Joseph13
Estimated H-index: 13
(Population Health Research Institute)
+ 36 AuthorsAndreas Wielgosz15
Estimated H-index: 15
(U of O: University of Ottawa)
Summary Background Global estimates of the effect of common modifiable risk factors on cardiovascular disease and mortality are largely based on data from separate studies, using different methodologies. The Prospective Urban Rural Epidemiology (PURE) study overcomes these limitations by using similar methods to prospectively measure the effect of modifiable risk factors on cardiovascular disease and mortality across 21 countries (spanning five continents) grouped by different economic levels. M...
Published on May 1, 2019in Gastroenterology19.23
Paul Moayyedi2
Estimated H-index: 2
(Population Health Research Institute),
John A. Eikelboom (Population Health Research Institute)+ 47 AuthorsKelley Branch1
Estimated H-index: 1
(University of Washington Medical Center)
Abstract Background & Aims Proton pump inhibitors (PPIs) are effective at treating acid-related disorders. These drugs are well tolerated in the short term, but long-term treatment was associated with adverse events in observational studies. We aimed to confirm these findings in an adequately powered randomized trial. Methods We performed a 3x2 partial factorial double-blind trial of 17,598 participants with stable cardiovascular disease and peripheral artery disease randomly assigned to groups ...
Published on Sep 1, 2019in Journal of the American College of Cardiology18.64
John W. Eikelboom89
Estimated H-index: 89
(HHS: Hamilton Health Sciences),
Jacqueline Bosch1
Estimated H-index: 1
(McMaster University)
+ 15 AuthorsDeepak L. Bhatt119
Estimated H-index: 119
(Brigham and Women's Hospital)
Abstract Background In patients with coronary or peripheral artery disease, the combination of rivaroxaban 2.5 mg twice daily and aspirin 100 mg once daily compared with aspirin 100 mg once daily reduced major adverse cardiovascular events and mortality and increased bleeding. Objectives This study sought to explore the effects of the combination of rivaroxaban and aspirin compared with aspirin on sites, timing, severity, and management of bleeding in the COMPASS (Cardiovascular Outcomes for Peo...
Published on Aug 18, 2019in BMC Cardiovascular Disorders1.95
Amand F. Schmidt9
Estimated H-index: 9
,
Michael V. Holmes30
Estimated H-index: 30
+ 164 AuthorsAlbert Henry
Dr Schmidt is supported by BHF grant PG/18/5033837. This research has been funded by the British Heart Foundation (SP/13/6/30554, RG/10/12/28456). The work was also supported by UCL Hospitals NIHR Biomedical Research Centre and by the Rosetrees and Stoneygate Trusts. This research has been conducted using the UK Biobank Resource under Application Number 12113. The authors are grateful to UK Biobank participants. UK Biobank was established by the Wellcome Trust medical charity, Medical Research C...
Published on Aug 1, 2019in Hypertension7.02
Andrew Mente30
Estimated H-index: 30
(Population Health Research Institute),
Martin O'Donnell50
Estimated H-index: 50
(National University of Ireland, Galway),
Salim Yusuf Mb Bs DPhil Frcpc209
Estimated H-index: 209
(Population Health Research Institute)
12345678910